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exposure to NM staff  and physicians despite of  adopting 
well‑known strategies of  time, distance, and shielding. In most 
of  NM departments in Pakistan, 131I is administered orally 
in a liquid form by the technologists and in our department 
patients were used to give liquid 131I in a disposable glass to 
drink. This indeed was a source of  significant but avoidable 
source of  radiation exposure to our technologists. Recently, we 
have designed an indigenous reasonably close delivery system 
for oral administration of  131I to patients with toxic goiters and 
well‑differentiated thyroid cancers.
MATERIALS AND METHODS
We used a thick lead container in which 131I vial is supplied and 
transported by the vendor. With the help of  our biomedical 
division, the lumen of  the thick lead vial container was broadened 
to accommodate a disposable plastic glass to be filled with 
liquid 131I. A small circular hole was also made in the center of  
cap (cover) of  lead vial container to insert a disposable straw to 
drink liquid 131I. To minimize radiation exposure from straw while 
patient is taking 131I, we have used a long cylindrical lead covering 
to house this straw. This lead cylinder to shield a straw was made 
from 1 mm thick semicircular lead linings around hot column of  
an expired 99Molybdenum‑99mTechnetium generator [Figure 1].
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INTRODUCTION
In nuclear medicine (NM) department, technologists are exposed 
to ionizing radiation in nuclear pharmacy while preparing and 
administering the radiopharmaceutical, in imaging room and also 
in handling the patients after the completion of  procedures. In a 
fairly busy NM department, the average radiation dose received 
by a technologist was below 5 milliSievert (mSv) and about 60% 
of  dose was received during injecting radiopharmaceuticals to 
the patients.[1] This is well below the annual dose limit of  20 mSv 
for radiation workers.[2] In recent days, there has been an increase 
use of  radioiodien‑131 (131I) for thyroid disorders[3] and also 131I 
labeled targeted radionuclide therapy for nonthyroidal cancers. 
For thyroid disorders, 131I is administered orally and for other 
target radionuclide therapies, an intravenous infusion is usually 
used. These procedures carry a potential risk of  significant 
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To assess the efficiency of  this indigenous, relatively close delivery 
system, we measured exposure rates at 1 m distance at patient’s 
torso level using a survey meter (VICTOREEN, Model no: 450, 
USA) with and without said system for various strength of  131I. 
It was tested in first 23 patients who were referred for iodine 
treatment to our department for benign and malignant thyroid 
disorders. This was a small prospective study conducted from 
April 2013 till 15th July 2013 at Nuclear Medicine Department 
of  Dr. Ziauddin Medical University, Karachi, Pakistan.
Statistical analysis
Data were analyzed by using commercially available packages 
the Medcalc® statistical software version 11.3.10 and statistical 
package for social sciences (SPSS version 17®). A two‑tailed 
student’s t‑test was used to compare continuous variables. 
Bland‑Altman’s plot was used to see the difference of  exposure 
rates with and without lead with mean values. P < 0.05 was 
considered significant.
RESULTS
We tested this system upon first 23 patients (17 females and 
6 males with a mean age of  49 ± 14 years). 131I therapy was 
administered for benign thyroid diseases in 13, while 10 patients 
had well‑differentiated thyroid cancers. The average administered 
dose of  131I for benign disease was 555 ± 148 MBq (15 ± 4 mCi) and 
for malignant conditions it was 5032 ± 1443 MBq (136 ± 39 mCi). 
Average measured exposure in milliRoentgen/hour (mR/h) at 
1 m distance without lead vial was 5.416 ± 3.423 and with lead it 
was 1.903 ± 1.254 [Table 1]. The difference between exposures 
rates with and without lead was analyzed by Bland‑Altman’s 
curve which revealed all the differences were close to the 
mean line and no significant outlier was noted [Figure 2]. The 
percentage reduction in exposure rate by using lead system was 
64 ± 6% [t‑test: −4.687, P < 0.05] [Figure 3].
DISCUSSION
In recent years, overwhelming use of  radiation‑based 
diagnostic and therapeutic procedures has been noticed. 
This has indeed been responsible for reported exorbitant 
radiation exposure to people[4] and also a matter of  serious 
concern for radiation workers. The annual radiation exposure 
of  our technologists has always been well below the statutory 
limits. But due to significant rise in referral of  radioiodine 
Figure 2: Bland‑Altman’s scatter plot of exposure rate difference with and without 
using lead container for radioactive iodine oral administration
Figure 3: Comparative analysis of exposure rate during oral administration of 
radioactive iodine with and without using lead container
Table 1: Patients’ demographic
Variables Total no. of patients (23)
Benign: Malignant indications 57%:43% (13:10)
Female: Male 74%:26% (17:06)
Average age±SD in years 49±14 years
Average dose administered in 
Ca thyroid (mean±SD in MBq)
5032±1443 MBq
Average dose administered in benign 
thyroid disease (mean±SD in MBq)
555±148 MBq
Average exposure±SD in mR/h 
without lead container
5.416±3.423
Average exposure±SD in mR/h with 
lead container
1.903±1.254
mR/h: MilliRoentgen/h, SD: Standard deviation, MBq: Mega becquerel
Figure 1: (a) Disposable glass and straw without lead shield for 131I treatment 
previously used; (b) Indigenously designed close delivery system with widened 
cavity of lead vial and an opening in top cover to insert a straw and; (c) Lead 
shielded straw and heavily shielded vial with liquid 131I
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therapies to our center since March 2013, we were skeptical 
about an increase in radiation exposure to our technologists. 
Following the As low as reasonable achievable (ALARA) 
principle, we considered to acquire commercially available close 
system for 131I delivery. However, cost of  such system was 
significantly high. This cost limitation had initiated the idea 
of  developing this system indigenously. The measured values 
of  exposure rates have shown efficacy of  this close system 
in minimizing the radiation exposure to our technologists. In 
Bland‑Altman’s curve with fall of  measured values close to the 
mean value also rules out outlier and reproducibility of  the 
measuring methodology. Literature search has revealed a close 
vacuum‑assisted system designed for administration of  high 
doses of  131I by Prabhakar et al., India.[5] No data regarding 
radiation exposure with and without vacuum‑assisted system 
were presented. In last few years, two important studies 
have pointed out increased incidence of  brain tumor in 
interventional cardiologist[6] and higher incidence of  cancer 
in offspring of  radiation workers.[7] These data are indeed 
alarming for radiation workers, but adopting every effort 
to minimize radiation exposures like developing indigenous 
close delivery system and its validity by on‑site measurement 
improves their confidence. The cost involved in developing 
this system was very nominal, but efficacy in terms of  
radiation safety and confidence of  our technologists were 
phenomenal.
REFERENCES
1. Lundberg TM, Gray PJ, Bartlett ML. Measuring and minimizing the 
radiation dose to nuclear medicine technologists. J Nucl Med Technol 
2002;30:25‑30.
2. National Council on Radiation Protection and Measurements. 
Ionizing radiation exposure of  the population of  the United States: 
Recommendation of  the National Council on Radiation Protection and 
Measurements. Report No. 160, Bethesda, MD: NCRP; 2009.
3. Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, 
et al. Annual report to the nation on the status of  cancer, 1973‑1999, 
featuring implications of  age and aging on U.S. cancer burden. Cancer 
2002;94:2766‑92.
4. Einstein AJ, Weiner SD, Bernheim A, Kulon M, Bokhari S, Johnson LL, 
et al. Multiple testing, cumulative radiation dose, and clinical indications in 
patients undergoing myocardial perfusion imaging. JAMA 2010;304:2137‑44.
5. Rao VP, Sudhakar P, Swamy VK, Pradeep G, Venugopa N. Closed system 
vacuum assisted administration of  high dose radio iodine to cancer thyroid 
patients: NIMS technique. Indian J Nucl Med 2010;25:34‑5.
6. Roguin A, Goldstein J, Bar O. Brain tumours among interventional 
cardiologists: A cause for alarm? Report of  four new cases from two cities 
and a review of  the literature. Euro Intervention 2012;7:1081‑6.
7. Johnson KJ, Alexander BH, Doody MM, Sigurdson AJ, Linet MS, 
Spector LG, et al. Childhood cancer in the offspring born in 1921‑1984 to 
US radiologic technologists. Br J Cancer 2008;99:545‑50.
How to cite this article: Fatima N, uz Zaman M, Shah IA, Ul Haq I, 
Javed A. Indigenously developed close delivery system for oral iodine‑131 
therapy: Nominal cost but phenomenal protection. Indian J Nucl Med 
2013;28:207‑9.
Source of Support: Nil. Conflict of Interest: None declared.
Staying in touch with the journal
1) Table of Contents (TOC) email alert 
 Receive an email alert containing the TOC when a new complete issue of the journal is made available online. To register for TOC alerts go to 
www.ijnm.in/signup.asp.
2) RSS feeds 
 Really Simple Syndication (RSS) helps you to get alerts on new publication right on your desktop without going to the journal’s website. 
You need a software (e.g. RSSReader, Feed Demon, FeedReader, My Yahoo!, NewsGator and NewzCrawler) to get advantage of this tool. 
RSS feeds can also be read through FireFox or Microsoft Outlook 2007. Once any of these small (and mostly free) software is installed, add 
www.ijnm.in/rssfeed.asp as one of the feeds.
[Downloaded free from http://www.ijnm.in on Wednesday, October 31, 2018, IP: 105.27.236.36]
